“Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study”, J of Skin, vol. 7, no. 2, p. s188, Mar. 2023, doi: 10.25251/skin.7.supp.188.